Nektar Therapeutics
NKTR
$57.13
$2.284.16%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 53.61% | -19.54% | -14.34% | 4.39% | -9.86% |
| Total Receivables | -4.59% | -21.18% | 6.53% | -24.21% | -26.77% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 36.18% | -21.51% | -12.03% | -11.93% | 20.00% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -1.04% | 2.99% | 277.97% | -94.74% | 778.33% |
| Total Current Assets | 50.81% | -18.85% | -12.01% | -8.79% | -2.95% |
|
|
|||||
| Total Current Assets | 50.81% | -18.85% | -12.01% | -8.79% | -2.95% |
| Net Property, Plant & Equipment | -5.45% | -5.27% | -5.61% | -4.87% | -49.12% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.63% | -6.81% | 16.01% | 2.83% | 4.75% |
| Total Assets | 45.20% | -19.01% | -15.67% | -1.34% | -10.30% |
|
|
|||||
| Total Accounts Payable | 8.98% | -19.92% | 54.27% | 34.78% | 32.46% |
| Total Accrued Expenses | -20.04% | 11.94% | 4.50% | -6.92% | 11.73% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 0.78% | 0.77% | 9.94% | -7.61% | 0.78% |
| Total Finance Division Other Current Liabilities | -3.85% | 15.93% | 2.10% | -66.57% | 146.53% |
| Total Other Current Liabilities | -3.85% | 15.93% | 2.10% | -66.57% | 146.53% |
| Total Current Liabilities | -7.08% | 0.65% | 15.52% | -9.15% | 17.89% |
|
|
|||||
| Total Current Liabilities | -7.08% | 0.65% | 15.52% | -9.15% | 17.89% |
| Long-Term Debt | -6.71% | -6.66% | -5.94% | -6.19% | -9.00% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -5.95% | -5.54% | -5.08% | -4.68% | -4.41% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -10.84% | -16.58% | -6.70% | 4.76% | -14.15% |
| Total Liabilities | -6.68% | -4.44% | -0.25% | -6.16% | -1.73% |
|
|
|||||
| Common Stock & APIC | 3.87% | 0.10% | 0.11% | 0.13% | 0.15% |
| Retained Earnings | -0.96% | -1.14% | -1.41% | 0.20% | -1.04% |
| Treasury Stock & Other | 101.86% | -1.79% | -0.75% | -11.12% | 24.30% |
| Total Common Equity | 451.44% | -276.23% | -77.38% | 24.25% | -38.66% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 451.44% | -276.23% | -77.38% | 24.25% | -38.66% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 451.44% | -276.23% | -77.38% | 24.25% | -38.66% |
|
|
|||||